These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10797605)

  • 41. Elevated IgA and IgM anticardiolipin antibodies in acute Kawasaki disease.
    Gupta M; Johann-Liang R; Bussel JB; Gersony WM; Lehman TJ
    Cardiology; 2002; 97(4):180-2. PubMed ID: 12145471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
    Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
    Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anticardiolipin antibodies: a study in cerebral venous thrombosis.
    Christopher R; Nagaraja D; Dixit NS; Narayanan CP
    Acta Neurol Scand; 1999 Feb; 99(2):121-4. PubMed ID: 10071172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Tormene D; Hoxha A; Fedrigo M; Simioni P
    Clin Chim Acta; 2015 Jun; 446():201-5. PubMed ID: 25935129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
    López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
    Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical laboratory testing for the antiphospholipid syndrome.
    Pierangeli SS; Harris EN
    Clin Chim Acta; 2005 Jul; 357(1):17-33. PubMed ID: 15893301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Variability in anticardiolipin antibody detection: role of nonspecific IgG binding and different microtiter plates.
    Pellegrino NM; Caccavo D
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):404-9. PubMed ID: 17911192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anticardiolipin, other antiphospholipid antibody tests and diagnosis of the antiphospholipid syndrome.
    Smikle M; Wharfe G; Fletcher H; Reid M; Roye-Green K; Fredrick J; Pierangeli S
    Hum Antibodies; 2003; 12(3):63-6. PubMed ID: 14646034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Classical and additional antiphospholipid antibodies in blood samples of ischemic stroke patients and healthy controls.
    Carmel-Neiderman NN; Tanne D; Goren I; Rotman-Pikielny P; Levy Y
    Immunol Res; 2017 Apr; 65(2):470-476. PubMed ID: 28116653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
    Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
    Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of anticardiolipin antibodies in patient cohorts with distinct clinical manifestations of the antiphospholipid syndrome.
    Damoiseaux J; Peeters L; Hupperts R; Boreas A; ten Cate H; Tervaert JW
    Ann N Y Acad Sci; 2009 Sep; 1173():146-51. PubMed ID: 19758143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome].
    Fujieda Y; Shida H; Oku K; Bohgaki T; Amengual O; Horita T; Yasuda S; Atsumi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):430-6. PubMed ID: 25744643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An automated chemiluminescence immunoassay may detect mostly relevant IgG anticardiolipin antibodies according to revised Sydney criteria.
    Noubouossie D; Valsamis J; Corazza F; Rozen L; Debaugnies F; Demulder A
    Acta Clin Belg; 2012; 67(3):184-9. PubMed ID: 22897066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Campello E; Hoxha A; Fedrigo M; Punzi L; Simioni P
    Clin Chem Lab Med; 2015 Jun; 53(7):1083-9. PubMed ID: 25720075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complement-fixing activity of anticardiolipin antibodies in patients with and without thrombosis.
    Shinzato MM; Bueno C; Trindade Viana VS; Borba EF; Gonçalves CR; Bonfá E
    Lupus; 2005; 14(12):953-8. PubMed ID: 16425575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and abeta2 glycoprotein-I is the most frequent isotype.
    Diri E; Cucurull E; Gharavi AE; Kapoor D; Mendez EA; Scopelitis E; Wilson WA
    Lupus; 1999; 8(4):263-8. PubMed ID: 10413203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phospholipid-independent binding of beta 2glycoprotein I by IgA from patients with antiphospholipid syndrome.
    Galazka MW; Keil LB; Kohles J; Petersheim M; DeBari VA
    Ann Clin Lab Sci; 1998; 28(3):153-9. PubMed ID: 9646856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-cardiolipin antibodies (IgG and IgA) in women with recurrent fetal loss correlate to clinical and serological characteristics of SLE.
    Bagger PV; Andersen V; Baslund B; Beck B; Hove H; Høier-Madsen M; Petersen J; Philip J; Schaadt O; Skouby SO
    Acta Obstet Gynecol Scand; 1993 Aug; 72(6):465-9. PubMed ID: 8394626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Significance of persistent antiphospholipid antibodies in the elderly.
    Quéméneur T; Lambert M; Hachulla E; Dubucquoi S; Caron C; Fauchais AL; Devulder B; Hatron PY
    J Rheumatol; 2006 Aug; 33(8):1559-62. PubMed ID: 16832847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.